Our results show that strategically targeting TIM3, LAG3, TIGIT, CTLA4, IFITM, TREM2 and PD-1 in MMRd and also MMRp CRC tumors not only further limits tumor growth but can also significantly increase the complete elimination of tumors. This evidence concerns the gene CTLA4 and colorectal carcinoma.